Mr. Barhorst is chair of The California State University Foundation. He is retired as president and chief executive officer of ING Financial Advisers, LLC and ING Investment Advisors, LLC and Systematized Benefits Administrators, Inc. He was also head of national accounts, healthcare and government markets. He previously served as director of residential services for Montgomery [...]
Managing Director, JC Capital. He was previously Managing Director, Head of European Equity Derivatives, and Head of Northern Europe, Barclays Capital, London, Managing Director and Head of Nordics, Credit Suisse, London and Vice President, Bankers Trust. Previous Board Member of Enter Card Europe.
Dr. Prince pioneered the prevention of the respiratory syncytial virus (RSV) disease in high-risk infants through the use of monoclonal antibody (Synagis®. is currently marketed through a partnership between MedImmune and Abbvie). Dr. Prince brings pharmaceutical research and development and commercialization expertise to the Scientific Advisory Board team. After earning doctorate degrees at UCLA (DDS, [...]
Chairman and CEO at Juneau Biosciences. Board certification in Obstetrics and Gynecology, Maternal Fetal Medicine, Molecular Genetics and Medical Genetics.
Dr. Taylor, a Chief of Obstetrics and Gynecology at Yale University, brings extensive clinical research and development expertise in endometriosis and women’s health to PRED’s Scientific Advisory Board team. Dr. Taylor’s many accomplishments include Anita O’Keeffe Young Professor and Chairs Department of Obstetrics Gynecology and Reproductive Sciences at Yale School of Medicine and Chief of [...]
Mr. Sorrentino is Vice-President and Chief Operating Officer of Vaccine Research and Development at Pfizer. During his more than 35 years of senior management experience in the life sciences industry, Mr. Sorrentino has held leadership roles in private and public companies, as well as government and non-profit institutions, with a focus on improving public health. [...]
Dr. Nelson an obstetrician and gynecologist from Salt Lake City, Utah, brings a wealth of experience to PRED. Predictive Technology Group, Inc., specializes in genetic testing, diagnostics, and therapeutic products to advance precision medicine. Dr. Nelson served as President of the American Medical Association, Salt Lake County Medical Society, and the Utah Medical Association. Also, [...]
A marketing and sales master for over 25 years, Michael Herbert brings his special brand of creativity and wit to the Predictive team. Driven by an entrepreneurial spirit, he specializes in business start-ups, product packaging and consumer experience. Michael’s previous experience includes ownership and leadership positions with some of the consumer sporting goods channels most [...]
Previously President, Sagent Technologies (medical device division of Sagent Pharmaceuticals), CEO/Co-Founder of Infusive Technologies (developer of drug delivery technologies) and Director/Co-Founder of Specialized Health Products, Inc., acquired by C.R. Bard, Inc. Mr. Robinson studied accounting at the University of Utah and received a Masters of International Management from the Thunderbird, The American Graduate School of [...]
Michael Dey, Ph.D. is a member of the Board of Directors of Predictive Technology Group, Inc. Dr. Dey will assist in corporate governance and guide the development and commercialization of technology and products in all PRED’s subsidiaries. In addition to serving as a PRED Board Member, Dr. Dey will continue as Chief Executive Officer of [...]